http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100418391-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C291-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C291-00 |
| filingDate | 2001-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100418391-B1 |
| titleOfInvention | Novel inhibitor hy52 against cell cycle regulating factor, preparation thereof and use thereof in anti-cancer agent |
| abstract | The present invention relates to a compound of formula 1 or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition comprising the same, wherein the compound of formula 1 according to the present invention or a pharmaceutically acceptable salt thereof is purely isolated from Bauhinia forficata . Since cancer cells have excellent cell cycle regulator inhibitory ability and apoptosis induction ability, they may be useful as cell cycle regulator inhibitors as well as anticancer agents.n n n n Formula 1 |
| priorityDate | 2001-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 184.